FDA Approves CYCLOPHOSPHAMIDE — Amneal Pharmaceuticals LLC
The FDA has approved a new oral formulation of generic Cyclophosphamide by Amneal Pharmaceuticals LLC, providing patients with a generic alternative to injectable options. This approval is expected to significantly reduce costs for cancer treatments and expand access to this essential chemotherapy agent.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed